
Biomarker types and colorectal cancer

Biomarkers 101
Learn the basics about biomarkers and colorectal cancer, why testing is important, and what learning about your biomarker mutations can mean for your treatment options and cancer outcomes.

Biomarker type resource guide
This resource grid details the different types of biomarkers and how they relate to a colorectal cancer diagnosis and treatment.

The Alliance’s personalized treatment program
The Alliance and Perthera have partnered to provide personalized treatment options to stage III and IV patients with colorectal cancer.
If you recently had molecular/biomarker testing, your results will be analyzed with no additional testing required.
Call us at the Alliance’s Helpline at (877) 422-2030 to enroll.
Related reading
SidednessTop resources

Alliance Reaches Out To Hispanic Population With Latest PSA
The nation’s leading nonprofit dedicated to ending colorectal cancer has launched Preventable, a new public service announcement, in Spanish and English. Watch it now.

Statement: SCOTUS Decision in Kennedy v. Braidwood Management, Inc.
The Colorectal Cancer Alliance applauds the Supreme Court’s decision in Kennedy v. Braidwood, preserving no-cost preventive care under the ACA—including lifesaving colorectal cancer screenings.

2025 ASCO update: Six big studies
The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.